Observation of clinical effect of pemetrexed and cisplatin combined with bevacizumab on first-line treatment of wild-type lung adenocarcinoma with epidermal growth factor receptor driven gene

Zhu Feng; Gao Huimin; Zhou Yunyun; Wang Xiaoyun

doi:10.3760/j.issn.1673-4777.2023.10.007

Home>Articles>Observation of clinical effect of pemetrexed and cisplatin combined with bevacizumab on first-line treatment of wild-type lung adenocarcinoma with epidermal growth factor receptor driven gene

DOI: 10.3760/j.issn.1673-4777.2023.10.007

Observation of clinical effect of pemetrexed and cisplatin combined with bevacizumab on first-line treatment of wild-type lung adenocarcinoma with epidermal growth factor receptor driven gene

Zhu Feng

Gao Huimin

Zhou Yunyun

Wang Xiaoyun

Keywords：Lung adenocarcinomaPemetrexedCisplatinBevacizumabEpidermal growth factor receptor

Publication Date：2023-10-08

Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)

Pages：5( 1470-1474 )

China Medicine

ISTIC

ISSN：1673-4777

Year, Vol.(Issue)：2023,18(10)